CLLS - Cellectis S.A.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue21,43233,71556,44462,565
Cost of Revenue2,7392,6201,7772,746
Gross Profit18,69331,09554,66759,819
Operating Expenses
Research Development76,56778,42978,45858,154
Selling General and Administrative47,24844,75043,41330,223
Non Recurring----
Others539-124992,425
Total Operating Expenses127,093125,675123,74793,548
Operating Income or Loss-105,661-91,960-67,303-30,983
Income from Continuing Operations
Total Other Income/Expenses Net17,328-11,723-1928,377
Earnings Before Interest and Taxes-105,661-91,960-67,303-30,983
Interest Expense-46-4-7-24
Income Before Tax-88,333-103,683-67,255-22,606
Income Tax Expense----
Minority Interest40,97019,1131,876787.402
Net Income From Continuing Ops-88,333-103,683-67,255-22,606
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-78,693-99,368-67,255-22,796
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-78,693-99,368-67,255-22,796